Clinical Trial Update: Study to Determine the Antitumor Activity of New CAR-macrophages in Breast Cancer Patients' Derived Organoids

View source ↗

Summary

A clinical trial is evaluating the antitumor activity of a novel CAR-macrophage therapy in breast cancer using patient-derived organoids. Recruitment is ongoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CAR-macrophage therapy (Chimeric antigen receptor macrophages)

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Breast Cancer | Status: RECRUITING